TY  - JOUR
T1  - PItuitary prolactinoma and estrogen contraceptives
AU  - Vaisrub S
Y1  - 1979/07/13
N1  - 10.1001/jama.1979.03300020047029
JO  - JAMA
SP  - 177
EP  - 178
VL  - 242
IS  - 2
N2  - It is most unusual for advocates of surgical therapy for a disease to concede that the efficacy of their operation merely approaches that of a competing medical therapy. Generally, surgery is held out as offering a prompt, radical cure that can only be approached but rarely matched by the slow and uncertain medical management. Thus, it is with admiration for the beguiling modesty we read in the article by Post et al (p 158) that the "therapeutic success of transsphenoidal surgery in grade I adenomas approaches the efficacy of bromocryptine." Surgery is the treatment of choice because of the frequent undesirable side effects of bromocryptine and, more important, because of the danger of pituitary tumor enlargement, particularly when pregnancy ensues after restoration of normal ovulation by the drug.Regardless of the relative merits of its surgical or medical therapy, galactorrhea and amenorrhea need no longer be a source of diagnostic
SN  - 0098-7484
M3  - doi: 10.1001/jama.1979.03300020047029
UR  - http://dx.doi.org/10.1001/jama.1979.03300020047029
ER  -